Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data

The generic reference price system (RPS) can impose a financial penalty for patients using a brand name drug instead of its generic alternative. Previous studies on the impact of the RPS have not considered the potentially differential effect of using generic alternatives for individuals with a diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Farfan-Portet, Maria-Isabel, Van de Voorde, Carine, Vrijens, France, Vander Stichele, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343229/
https://www.ncbi.nlm.nih.gov/pubmed/22427042
http://dx.doi.org/10.1007/s10198-012-0377-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343229/
https://www.ncbi.nlm.nih.gov/pubmed/22427042
http://dx.doi.org/10.1007/s10198-012-0377-8

Ejemplares similares